| Original language | English |
|---|---|
| Pages (from-to) | 967-969 |
| Number of pages | 3 |
| Journal | Annals of the American Thoracic Society |
| Volume | 13 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2016 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Annals of the American Thoracic Society, Vol. 13, No. 6, 06.2016, p. 967-969.
Research output: Contribution to journal › Review article › peer-review
TY - JOUR
T1 - Pediatric pulmonary hypertension
AU - Boyer, Debra
AU - Pittman, Jessica E.
AU - Dy, Fei Jamie
AU - Arunachalam, Ambalavanan
AU - Dweik, Raed A.
AU - Abman, Steven H.
AU - Wilson, Kevin C.
AU - Thomson, Carey C.
N1 - Funding Information: The University of Colorado School of Medicine has received consulting fees for Dr. Ivy from Actelion, Bayer, Gilead, Eli Lilly, Pfizer, and United Therapeutics. The University Medical Center Groningen has received consulting fees for Dr. Berger from Actelion, Bayer, GlaxoSmithKline, Lilly, Novartis, and Pfizer. Dr. Berger has performed consultancies for Actelion, Bayer, GlaxoSmithKline, Lilly, Novartis, Pfizer, and United Therapeutics. Dr. Bonnet has received lecture and consulting honoraria from Actelion, Eli Lilly, Pfizer, and Bayer. Dr. Fleming has served as a consultant to Actelion and Pfizer. Dr. Haworth has received consulting fees from GlaxoSmithKline. Dr. Rosenzweig has received research grant support from Actelion, Gilead, GlaxoSmithKline, Eli Lilly, Bayer, and United Therapeutics ; and consulting honoraria from United Therapeutics and Actelion. The University of California has received consulting fees for Dr. Steinhorn from Ikaria and United Therapeutics, and she has served as an unpaid consultant to Actelion. Dr. Beghetti has served as an advisory board member for Actelion, Bayer, Eli Lilly, GlaxoSmithKline, Novartis, and Pfizer; has received grants from Actelion and Bayer ; has receiving lecture fees from Actelion, Bayer, and Pfizer; has developed educational materials for Actelion and Pfizer; and has receiving consulting fees from Actelion, Bayer, GlaxoSmithKline, Pfizer, and Novartis. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2016/6
Y1 - 2016/6
UR - http://www.scopus.com/inward/record.url?scp=84989284868&partnerID=8YFLogxK
U2 - 10.1513/AnnalsATS.201602-110CME
DO - 10.1513/AnnalsATS.201602-110CME
M3 - Review article
C2 - 27295157
AN - SCOPUS:84989284868
SN - 2325-6621
VL - 13
SP - 967
EP - 969
JO - Annals of the American Thoracic Society
JF - Annals of the American Thoracic Society
IS - 6
ER -